{"name":"Medicenna Therapeutics, Inc.","slug":"medicenna-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"MDNA11","genericName":"MDNA11","slug":"mdna11","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"MDNA11","genericName":"MDNA11","slug":"mdna11","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxNQmVQMTFxeVVDOGdvN29DUW15VnRVTHgxR1VMVXgyTTJ1TFl3V05HTVJWY3VCWGFXZXlYMnUzMThYRkFic1pFWWUzWFRteTRZdFVxNkk2RGpxQXd0NGNKaWg3ZTUyR3JQTVpHbHBlZGZ3SHc0ZGU0U1l3TmtoN3laM2Y3NXNkVUxqWFhRV0xRd2pWLUVSNFJFQ05oZjBIeEhCSUFhVTdQY3R6bEQzTksyNDV4LWpvRUZoU2M2bmZHMmp0dDliRHJvMU9QWEJ6b1BndWJxb3NvWWRxWjA0cXpia012dDlyR25POXZid0JISC1uU0VKX2c?oc=5","date":"2026-04-01","type":"trial","source":"Barchart.com","summary":"Glioma Clinical Trial Pipeline Appears Robust With 180+ Key Pharma Companies Actively Working in the Domain | DelveInsight - Barchart.com","headline":"Glioma Clinical Trial Pipeline Appears Robust With 180+ Key Pharma Companies Actively Working in the Domain | DelveInsig","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE5fYVV3YzYxSVdYLWk5RGd6cWVZa1RsZDEydDBzS0cza1lqT1lJay1tWUZ6S1pFYm5wZTlRcjExczY5OHE3bWRwVzZXWWJvaXZ4WmpQSGhpdjR2UkQwbWNHb25XUUM3OGZUeDZGM2JxTkZFYVJzVWNHWQ?oc=5","date":"2026-03-24","type":"trial","source":"Market Data Forecast","summary":"Glioblastoma Market Size, Share & Growth Report, 2034 - Market Data Forecast","headline":"Glioblastoma Market Size, Share & Growth Report, 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQY0EyRFZ3NjVXbWN2Mzh2aDNJZS1GR3pmR3d4VHd1MUxMVElCb21LYjdUQjctZUcyQ1NJY1BKWldKVkpnZVRVMVhHZVRhUVViZHAyejBtMnRxSlFlV0xfaGdhVC0wd2huQi13Tk5uUGpjWGFkX1pHNGVHWDF2UnFQdUdmVF9WSHowcVlab1ZJbUxvSFBKcWc?oc=5","date":"2026-03-20","type":"pipeline","source":"openPR.com","summary":"Glioma Pipeline Expands as 180+ Pharma Companies Advance - openPR.com","headline":"Glioma Pipeline Expands as 180+ Pharma Companies Advance","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AJBVV95cUxQOGdNMTN1RElfTmhkU0xLTTZlV3Z4OTNEUjFyYjJLNzVjaFdUbDVHSjFrUXREZjAyLXF5clh4Q2x4U29Eb2loQkttODdYOVlUd2hFZkxPOEJDV0xIdEQ1OGZEaUQxMHVCR09NLS1Cd19QS0JxX3M5Q1I2RGtHQUpxTlZ2ZGpvUTNJdVo5ejQ5MGktaC1fdE85MnliWVc5eHpwdnZyMXhQU1d5N01MX3ItZktMLTd0bW5fcTVxNDVOeU44YnFSd3FjVWt6LXhhcXRadnAtRGlNYTR4MmlQbkNaY01fZTJLek1vWXdfRzZxV1FKSVNXV0RwbThRR21NNUlwbFExSG9CVnhuLVhiZFlkWHYwYXdJQzR3SGZSQzl6MS1HRjVZOTNKTTVzdm1RTmRwRVc0MWdrMTVMa2RQRTFaSlZncFNKVGJBYS1ibzdBNHI?oc=5","date":"2026-03-19","type":"pipeline","source":"Barchart.com","summary":"Glioma Pipeline Expands as 180+ Pharma Companies Advance Several Novel Therapies, Finds DelveInsight | Aivita Biomedical, Denovo BioPharma, Medicenna Therapeutics, Eli Lilly, Candel Therapeutics - Bar","headline":"Glioma Pipeline Expands as 180+ Pharma Companies Advance Several Novel Therapies, Finds DelveInsight | Aivita Biomedical","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwJBVV95cUxOQnVMZjBIMnRadVZZWkJTZGdNU3E0YkV6blU4ZTZwbEVuV09udVJvZDEzTFRmcjhjb1NhRDctNktxUHA1SmViU0xNYVNZejhOUS1XeFJVR3A2VzQ2MjAweE9EdHJJVzhMV0cxYUM0eF9CV0drVXhwbmQ2bHF2YzE5U2M5V0I5cUhtMXdFM1NjckE1dGhXR21uMzBfeWtaWEtkMkdkZnFZd1NDc3NldFFmVndCUEF3elRtNUJGMUpkLWF0UV9ITHpTOURBVS1KY3ZTN24tMWMzMlEyaGdVUXlLZ2JFRE5wWHhUODVFRGxfQlJTSXVkeTMtclBIbXVSQjJEdGxOSHFYdmxvRmtYUDN5RDdIY1NaRmZhQlpORm1oeXo1alRXbzh6SVUzT25SUlhWN3RXMkJJX1dFS2MyTF8wVjZzVGRqNkU?oc=5","date":"2025-10-23","type":"pipeline","source":"PR Newswire","summary":"Mismatch Repair Deficiency Market Forecasts Strong Expansion During the Forecast Period (2025-2034) Driven by Rising Diagnostics and Immuno-Oncology Advances | DelveInsight - PR Newswire","headline":"Mismatch Repair Deficiency Market Forecasts Strong Expansion During the Forecast Period (2025-2034) Driven by Rising Dia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wJBVV95cUxNeWEyc0ZSQ29fczhyMHUxMG1ZUmk1YmM5bVdSOE1kOTFqQl9PRWZOV1FyMXJFdTZjSmNZdUwta3gySjJmN09xbkYydDhVQnRGU3E4RTJvb3Q1NnZSbzdLVmdoNTBhQUROT2hrbWRza3NFb2YzR1QtV3htZkFlbmNyWGM0anBEcXdzQ3NnZVpzdTVRX0FOenZJeDA1UVVWVTluai1yWS1QMWRWNExWTkxSMnBJZUdQUDE1Q1h1VGcyam1mdDlNbDJydTVTenUzZ1ZieWZkZGNKeVhJaXVway05RWxucnhjMkxMZFl4bkpleHhtaEJYQlhHXzhYcEt6LXpUVzVWLXdjUDFGbEl0UjBlenpORUp3Y3hqZFdUeFBzaW9XM2xnSV9IOG1VLXNQN3hZb1pPcEtfR0dZakZsRXFkeFBpdURTX3pDa1BXT1FpZjRmLXM?oc=5","date":"2025-09-17","type":"pipeline","source":"PR Newswire","summary":"Interleukin-13 Inhibitors Market Predicted to Surge During the Forecast Period (2025-2034) Due to Breakthrough Therapies in Atopic Dermatitis, Asthma, CRSwNP, and Others | DelveInsight - PR Newswire","headline":"Interleukin-13 Inhibitors Market Predicted to Surge During the Forecast Period (2025-2034) Due to Breakthrough Therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxOenpaNm55eEJpdVN4SGFNY2trVlFnZEM5S0ROTl9nZTYyVXpjdEJ5QkprUkVGTWtoYVJjOTVaSC1taEhyTXhxYjVmNlhyeVU0dVNmb2dFYWU0VUc1RXVKNUJHOEVyVnRvMVJFNlM5M0FhUlRodC1iQ0MxbmJ2blFTVUx6NHVnT0M0TUdFbVM4emt2LXd4WEM0TVJyUk1vOWkzbE1MSEhiclp1WFhURHJCS0JfSkMySVJoQlZqdkd4YU5tcTBERmtlcHE0S0l5U0pQMUs4M1MtNUIxNWhPV2Z4ZVA1YlltdThCU3FkUGJnS2VVUWZ2V2c?oc=5","date":"2025-08-05","type":"deal","source":"The Globe and Mail","summary":"H.C. Wainwright Reaffirms Their Buy Rating on Medicenna Therapeutics Corp (MDNA) - The Globe and Mail","headline":"H.C. Wainwright Reaffirms Their Buy Rating on Medicenna Therapeutics Corp (MDNA)","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-01-27","type":"trial","source":"GlobeNewswire","summary":"Glioblastoma Market, an Area With High Trial Failure And - GlobeNewswire","headline":"Glioblastoma Market, an Area With High Trial Failure And","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE9oRDIyNzJ3WlhTYTJXZkJULVlNM1NuS3l2RmptSW9MeGNkUk5LWThNTUtiY0Q0ckZmaGwtUGhTM3lBZEFaZnVBVDEzQndJMmlIN0l2Z3UxekJ5UklIeERHUzJvYjdIVGtXZkoxazEyWWpzSjVIbFRF?oc=5","date":"2024-06-27","type":"pipeline","source":"The Pharma Letter","summary":"Medicenna Therapeutics - The Pharma Letter","headline":"Medicenna Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE1jejRwTHAxQnFJR0NTSEhxUVdFamY3VTNxcEJnMWVKcEVzaEdScmRfYVUxajlydE4zeTZKRWRrMWc4T0g1N1ZCR3VYU0pxTDZ1a1F5MmlB?oc=5","date":"2024-02-17","type":"pipeline","source":"Yahoo! Finance Canada","summary":"Satellos Bioscience Inc. (MSCL.TO) Stock Price, News, Quote & History - Yahoo! Finance Canada","headline":"Satellos Bioscience Inc. (MSCL.TO) Stock Price, News, Quote & History - Yahoo! Finance Canada","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNcmh0WjU3U2ZiTXlaRk12Q1ZrdXNpRTM3OVBoWWYxUTlZNzhWNXBWYmFvblVjaVRpTXpsakl5dTd6LTlmSzBWZWdwTmtqVnRhbXZQYUtzZHU2UEtORFh0WGllb19QX0s4STRnOFNoYm11VkpMRGNTUzAwak16cWktXzhIMVFMV2kzd0RkbVYwVGVNcDh4d05DLU5sZW5iS1hNRWlNUg?oc=5","date":"2023-11-03","type":"pipeline","source":"Fierce Biotech","summary":"Chutes & Ladders—Longtime BioMarin CEO hands baton off to Genentech chief - Fierce Biotech","headline":"Chutes & Ladders—Longtime BioMarin CEO hands baton off to Genentech chief","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wJBVV95cUxQeVhsa2xJM0s1LVRQQ2pJVEFhcmNfQ3NUQV9URkJwRlJpUDJEdTFLaFIwUS03ckd0bU9tcmFyRFZQdXFSMUhZVmV2RlE5aVR6SkVoZGt4dVFwTmZtSGxmcThqYmxwbm13VnduZXR5T0t2WkF1dnN1RXpsYTRoN0ZBbWpwNDFybTJ6ejZiMHd0SU80SXk3V0xUSm15cTRRbGlRMllGQkdSdVdmVkJmdFI5cGdJR3RvbVZEME5adTNWWklldk5RQ0FHOXkwTVNBZVRkMUZZeDBMYmZEQ211S2tGSC1SelZWMUx2NHFrLXV5d1pablJXa2hfcGg0eUtGVGlLT0FyaGtqSWRHLW10NzZ3RDZYaDFkb1Nwam50ZWFjaDJHRkVDOTRFY1B2M09tVTJ3VW5PQ1RJWjRQeGpGV1FZNjUxU2JyVEhmRjVZa1Jiek9kb2hnN3lmVWhGdw?oc=5","date":"2023-03-22","type":"pipeline","source":"GlobeNewswire","summary":"Brain Cancer Market Size to Propel With the Active - GlobeNewswire","headline":"Brain Cancer Market Size to Propel With the Active","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}